Investigator site

Pittsburgh, Pennsylvania 15232

0 studies enrolling now · 9 studies all time

What they study most

Acquired Thrombotic Thrombocytopenic Purpura, Clostridioides Difficile Infection, Clostridium Difficile Infection, Lupus Erythematosus, Systemic, Mycosis Fungoides, Nasal Polyposis, Pulmonary Arterial Hypertension

Studies at this site

• OPsumit USers Registry — Completed
• ECOSPOR III - SER-109 Versus Placebo in the Treatment of Adults With Recurrent Clostridium Difficile Infection — Completed
• ECOSPOR IV: An Open-Label Study Evaluating SER-109 in Recurrent Clostridioides Difficile Infection — Completed
• Phase III Trial With Caplacizumab in Patients With Acquired Thrombotic Thrombocytopenic Purpura — Completed
• Study to Assess Efficacy and Safety of Anti-von Willebrand Factor (vWF) Nanobody in Patients With Acquired Thrombotic Thrombocytopenic Purpura (aTTP) — Completed
• Follow-up Study for Patients Who Completed Study ALX0681-C301 (Post-HERCULES) — Completed
• Study to Evaluate Multiple Doses in Patients With Nasal Polyposis — Completed
• Clinical Study Assessing Outcomes, Adverse Events, Treatment Patterns, and Quality of Life in Patients Diagnosed With Mycosis Fungoides Cutaneous T-cell Lymphoma — Completed
• A Phase II Study to Evaluate Safety and Efficacy of ALX-0061 in Subjects With Systemic Lupus Erythematosus — Completed